Yoo BK - Search Results

1

In Vitro Cytotoxicity and Bioavailability of Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin.

Vijayakumar A, Baskaran R, Baek JH, Sundaramoorthy P, Yoo BK. Vijayakumar A, et al. Among authors: yoo bk. AAPS PharmSciTech. 2019 Jan 23;20(2):88. doi: 10.1208/s12249-019-1295-1. AAPS PharmSciTech. 2019. PMID: 30675630

2

Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity.

Baskaran R, Madheswaran T, Sundaramoorthy P, Kim HM, Yoo BK. Baskaran R, et al. Among authors: yoo bk. Int J Nanomedicine. 2014 Jun 26;9:3119-30. doi: 10.2147/IJN.S61823. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25061290 Free PMC article.

3

Quercetin-Loaded Solid Lipid Nanoparticle Dispersion with Improved Physicochemical Properties and Cellular Uptake.

Vijayakumar A, Baskaran R, Jang YS, Oh SH, Yoo BK. Vijayakumar A, et al. Among authors: yoo bk. AAPS PharmSciTech. 2017 Apr;18(3):875-883. doi: 10.1208/s12249-016-0573-4. Epub 2016 Jul 1. AAPS PharmSciTech. 2017. PMID: 27368922

4

Ginsenoside improves physicochemical properties and bioavailability of curcumin-loaded nanostructured lipid carrier.

Vijayakumar A, Baskaran R, Maeng HJ, Yoo BK. Vijayakumar A, et al. Among authors: yoo bk. Arch Pharm Res. 2017 Jul;40(7):864-874. doi: 10.1007/s12272-017-0930-1. Epub 2017 Jul 15. Arch Pharm Res. 2017. PMID: 28712035

5

Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer.

Jeon Y, Sym SJ, Yoo BK, Baek JH. Jeon Y, et al. Among authors: yoo bk. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221105498. doi: 10.1177/15347354221105498. Integr Cancer Ther. 2022. PMID: 35695002 Free PMC article.

6

In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles.

Madheswaran T, Baskaran R, Yoo BK, Kesharwani P. Madheswaran T, et al. Among authors: yoo bk. J Pharm Sci. 2017 Nov;106(11):3385-3394. doi: 10.1016/j.xphs.2017.06.016. Epub 2017 Jun 23. J Pharm Sci. 2017. PMID: 28652158

7

Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.

Madheswaran T, Baskaran R, Thapa RK, Rhyu JY, Choi HY, Kim JO, Yong CS, Yoo BK. Madheswaran T, et al. Among authors: yoo bk. AAPS PharmSciTech. 2013 Mar;14(1):45-52. doi: 10.1208/s12249-012-9888-y. Epub 2012 Dec 4. AAPS PharmSciTech. 2013. PMID: 23207960 Free PMC article.

8

Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants.

Madheswaran T, Baskaran R, Yong CS, Yoo BK. Madheswaran T, et al. Among authors: yoo bk. AAPS PharmSciTech. 2014 Feb;15(1):44-51. doi: 10.1208/s12249-013-0034-2. Epub 2013 Sep 25. AAPS PharmSciTech. 2014. PMID: 24222268 Free PMC article.

9

Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles.

Madheswaran T, Baskaran R, Sundaramoorthy P, Yoo BK. Madheswaran T, et al. Among authors: yoo bk. Arch Pharm Res. 2015 Apr;38(4):534-42. doi: 10.1007/s12272-014-0464-8. Epub 2014 Aug 2. Arch Pharm Res. 2015. PMID: 25085659

10

Skin permeation and retention of topical bead formulation containing tranexamic acid.

Vijayakumar A, Baskaran R, Yoo BK. Vijayakumar A, et al. Among authors: yoo bk. J Cosmet Laser Ther. 2017 Feb;19(1):68-74. doi: 10.1080/14764172.2016.1247965. Epub 2016 Nov 23. J Cosmet Laser Ther. 2017. PMID: 27762649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters